Mpox (Affenpocken)

Mpox (monkeypox) is a thematic concept centered on prevention, detection, and treatment of orthopoxvirus infections. Core tracks span vaccines and antivirals, PCR/rapid diagnostics, epidemiological surveillance and digital tracing, infection-control/PPE, and public-health logistics.The sector's total market cap is 377.02 billion USD, with a 24h change of +2.73%. Among 5 constituents, 3 are up (60.00%) and 2 are down (40.00%). The top gainer is Gilead Sciences Inc (GILD), with a 24h increase of +3.00%.Leadership-led rebound with uneven breadth suggests selective risk-on. Favor liquid, high-quality antiviral/vaccine leaders; trade strength with tight stops, and add on confirmed clinical, supply, or regulatory catalysts.